Clinical trial Recruiting at 1 site Observational Ages 50 and up

Registry for people with cerebral small vessel disease.

Official title: Real-world Patient Registry Study of Cerebral Small Vessel Disease

Run by Dongzhimen Hospital, Beijing · NCT07342075 · Data updated 2026-11-12

This project will collect clinical information and MRI scans from people aged 50 and older with MRI signs of cerebral small vessel disease to see how the condition relates to thinking, walking, and daily function over time.

Quick facts

Study typeObservational
Ages50 Years and up
SexAll
Enrollment50 (estimated)
SponsorDongzhimen Hospital, Beijing
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedNovember 13, 2025
Main results expectedAugust 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 15, 2026
Trial IDNCT07342075 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50 or older with MRI-confirmed typical imaging changes of cerebral small vessel disease who can provide informed consent and attend the Beijing study site.

Probably not a fit

People with recent acute ischemic stroke or intracranial hemorrhage, significant non-vascular white matter disease, other known causes of cognitive impairment, or severe organ failure are excluded and therefore unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry enrolling adults aged 50 and older with MRI-confirmed cerebral small vessel disease. Participants will undergo standardized MRI (including diffusion tensor imaging), clinical evaluations, and cognitive testing at baseline and at planned follow-up visits to track changes over time. Key exclusions include recent large stroke or intracranial hemorrhage, significant non-vascular white matter disease, and other known causes of cognitive impairment to keep the cohort specific to CSVD. Collected data aim to link imaging features with clinical and cognitive outcomes to inform future targeted interventions.

Why it matters

Potential benefit: If successful, the registry could improve diagnosis and prognosis of CSVD and help researchers design targeted treatments for CSVD-related cognitive decline.

How similar studies have gone: Previous observational registries and imaging studies have linked CSVD imaging markers to cognitive and motor outcomes, but registry data have not yet produced proven targeted therapies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age above 50 years (including 50-year-old);
2. MRI confirmed the presence of typical imaging changes of CSVD;
3. Voluntary participation in the study and be willing to sign the Informed Consent Form.

Exclusion Criteria:

1. Patients with acute ischemic stroke or acute intracranial hemorrhage (e.g., epidural hematoma, subdural hematoma, subarachnoid hemorrhage, intracerebral hemorrhage, etc.) or a history of cerebral infarction (non-lacunar) or intracranial hemorrhage within the past 3 months;
2. Significant non-vascular white matter lesions (e.g., multiple sclerosis, adult-onset leukoencephalopathy, metabolic encephalopathy, etc.);
3. Patients with a history of cognitive impairment due to other causes (e.g., normal pressure hydrocephalus, Alzheimer's disease, Parkinson's disease, multiple sclerosis, encephalitis, etc.);
4. Severe hepatic, renal, or cardiac insufficiency (ALT or AST \>2 times the upper limit of normal, or serum creatinine \>1.5 times the upper limit of normal, or New York Heart Association \[NYHA\] functional class III or IV);
5. Patients with psychiatric disorders that affect study medication administration and evaluation;
6. Contraindications to MRI examination (e.g., claustrophobia, presence of an implantable pacemaker, etc.);
7. Patients unable to comply with follow-up examinations or other study procedures due to residential location or other reasons;
8. Participation in other clinical trial projects.

Where it's running

  • Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.